[TINCTURE] Jerusalem Balsam

$19.95

The Jerusalem Balsam was developed approximately 300 years ago by Antonio Menzani Di Cuna, a monk in the Franciscan Monastery in the Old City of Jerusalem, who worked as a doctor and pharmacist. At that time the Balsam served both internally and externally for a broad range of acute and chronic illments. In 2005, an Israeli research team published its research on the Jerusalem Balsam in the highly respected Journal of Ethnopharmacology. The summary of their research findings indicate that the formula has various pharmacological actions; including anti-inflammatory and antiseptic activities.

Research supported actions for the Ingredients

Anti-infective, anti-inflammatory, antifungal, antibacterial, anti-viral, anti-parasitic.

Research supported indications for the Ingredients

Infections with helicobacter Pylori, peptic ulcers, inflammatory bowel diseases, Candida, haemorrhoids, flu, throat infections, wounds, ulcers

Safety precautions

Do not take for more than three months without professional supervision.

Dosage and mode of administration

For internal use: 3-5 droppers in a quarter of a glass of water twice a day, or as needed. For external use: For direct application onto injuries, wounds, ulcers and infections

Ingredients

Myrrh (Commiphora myrrha)

Frankincense (Boswellia sacra)

Mastic (Pistacia lentiscus)

Aloe (Aloe vera)

Studies and references

A summary of the research findings on Jerusalem Balsam indicate a broad range of actions including, among others; anti-inflammatory, disinfectant, and significant anti-infective actions. Modern scientific research confirms some of the ancient uses of the original Jerusalem Balsam. (Journal of Ethnopharmacology 101 (2005) 16-26)

Laboratory research which examined two sesquiterpenes from myrrh resin showed antibacterial activity against the Pseudomonas aeruginos bacteria, Ecoli and Staphylococcus aureus. Additionally, these two substances also showed antifungal activity against Candida albicans. (Planta Med. 2000 May; 66(4):356-8)